Trinity Biotech PLC (TRIB)
1.28
-0.02
(-1.54%)
USD |
NASDAQ |
Nov 21, 16:00
1.28
0.00 (0.00%)
After-Hours: 19:31
Trinity Biotech Price: 1.28 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 1.27 | 1.40 | 1.27 | 1.30 | 44606.00 |
Nov 19, 2024 | 1.27 | 1.324 | 1.265 | 1.32 | 44297.00 |
Nov 18, 2024 | 1.32 | 1.44 | 1.24 | 1.299 | 102394.0 |
Nov 15, 2024 | 1.34 | 1.53 | 1.34 | 1.37 | 51631.00 |
Nov 14, 2024 | 1.53 | 1.66 | 1.30 | 1.48 | 57289.00 |
Nov 13, 2024 | 1.57 | 1.68 | 1.49 | 1.55 | 98350.00 |
Nov 12, 2024 | 1.65 | 1.68 | 1.56 | 1.61 | 67137.00 |
Nov 11, 2024 | 1.63 | 1.70 | 1.534 | 1.63 | 95806.00 |
Nov 08, 2024 | 1.62 | 1.67 | 1.60 | 1.61 | 47974.00 |
Nov 07, 2024 | 1.68 | 1.922 | 1.631 | 1.680 | 32269.00 |
Nov 06, 2024 | 1.73 | 1.73 | 1.62 | 1.67 | 96499.00 |
Nov 05, 2024 | 1.69 | 1.90 | 1.626 | 1.73 | 26117.00 |
Nov 04, 2024 | 1.67 | 1.75 | 1.62 | 1.69 | 52107.00 |
Nov 01, 2024 | 1.72 | 1.76 | 1.67 | 1.69 | 65228.00 |
Oct 31, 2024 | 1.85 | 1.885 | 1.72 | 1.76 | 56174.00 |
Oct 30, 2024 | 2.00 | 2.05 | 1.84 | 1.87 | 120842.0 |
Oct 29, 2024 | 2.18 | 2.18 | 1.99 | 2.02 | 179071.0 |
Oct 28, 2024 | 1.98 | 2.21 | 1.97 | 2.20 | 364950.0 |
Oct 25, 2024 | 1.81 | 2.11 | 1.79 | 1.93 | 862198.0 |
Oct 24, 2024 | 1.56 | 2.05 | 1.55 | 1.83 | 827585.0 |
Oct 23, 2024 | 1.61 | 1.61 | 1.52 | 1.55 | 65882.00 |
Oct 22, 2024 | 1.63 | 1.63 | 1.52 | 1.55 | 95871.00 |
Oct 21, 2024 | 1.71 | 1.729 | 1.61 | 1.63 | 81502.00 |
Oct 18, 2024 | 1.77 | 1.783 | 1.67 | 1.71 | 57782.00 |
Oct 17, 2024 | 1.80 | 1.83 | 1.72 | 1.755 | 158436.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.09
Minimum
Sep 27 2024
33.20
Maximum
Feb 16 2021
7.658
Average
5.75
Median
Feb 10 2020
Price Benchmarks
Amarin Corp PLC | 0.525 |
DBV Technologies SA | 0.485 |
Ascendis Pharma AS | 122.73 |
Cellectis SA | 1.88 |
Adaptimmune Therapeutics PLC | 0.634 |
Price Related Metrics
PS Ratio | 0.2373 |
Earnings Yield | -178.1% |
Market Cap | 12.12M |